Skip to main content Accessibility help
×
Home

Omega-3 index in 2018/19

  • Clemens von Schacky (a1)

Abstract

The omega-3 index, the percentage of EPA plus DHA in erythrocytes (measured by standardised analysis), represents a human body's status in EPA and DHA. An omega-3 index is measured in many laboratories around the world; however, even small differences in analytical methods entail large differences in results. Nevertheless, results are frequently related to the target range of 8–11 %, defined for the original and scientifically validated method (HS-Omega-3 Index®), raising ethical issues, and calling for standardisation. No human subject has an omega-3 index <2 %, indicating a vital minimum. Thus, the absence of EPA and DHA cannot be tested against presence. Moreover, clinical events correlate with levels, less with the dose of EPA and DHA, and the bioavailability of EPA and DHA varies inter-individually. Therefore, the effects of EPA and DHA are difficult to demonstrate using typical drug trial methods. Recent epidemiologic data further support the relevance of the omega-3 index in the cardiovascular field, since total mortality, cardiovascular mortality, cardiovascular events such as myocardial infarction or stroke, or blood pressure all correlate inversely with the omega-3 index. The omega-3 index directly correlates with complex brain functions. Compiling recent data supports the target range for the omega-3 index of 8–11 % in pregnancy. Many other potential applications have emerged. Some, but not all health issues mentioned have already been demonstrated to be improved by increasing intake of EPA and DHA. Increasing the omega-3 index into the target range of 8–11 % with individualised doses of toxin-free sources for EPA and DHA is tolerable and safe.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Omega-3 index in 2018/19
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Omega-3 index in 2018/19
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Omega-3 index in 2018/19
      Available formats
      ×

Copyright

This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike licence (http://creativecommons.org/licenses/by-nc-sa/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the same Creative Commons licence is included and the original work is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use.

Corresponding author

Corresponding author: Clemens von Schacky, email c.vonschacky@omegametrix.eu

References

Hide All
1.Harris, WS & von Schacky, C (2004) The omega-3 index: a new risk factor for death from CHD? Prev Med 39, 212220.
2.Harris, WS, von Schacky, C & Park, Y (2013) Standardizing methods for assessing omega-3 fatty acid biostatus. In The Omega-3 Fatty Acid Deficiency Syndrome, pp. 385398. [McNamara, RK, editor]. Hauppauge, NY: Nova Science Publishers.
3.Harris, WS, Tintle, NL, Etherton, MR et al. (2018) Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: the Framingham Heart Study. J Clin Lipidol 12, 718727.
4.Kleber, ME, Delgado, GE, Lorkowski, S et al. (2016) Omega-3 fatty acids and mortality in patients referred for coronary angiography – the Ludwigshafen risk and cardiovascular health study. Atherosclerosis 252, 157181.
5.Harris, WS, Luo, J, Pottala, JV et al. (2017) Red blood cell polyunsaturated fatty acids and mortality in the womens’ health initiative study. J Clin Lipidol 11, 250259.
6.Yokoyama, M, Origasa, H, Matsuzaki, M et al. (2007) Japan EPA lipid intervention study (JELIS) Investigators (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369, 10901098.
7.Bhatt, DL, Steg, PG, Miller, M et al. (2019) Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 380, 1122.
8.Sarter, B, Kelsey, KS, Schwartz, TA et al. (2015) Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement. Clin Nutr 34, 212218.
9.Langlois, K & Ratnayake, WMN (2015) Omega-3 index of Canadian adults. Statistics Canada, Catalogue No. 82–003-X. Health Rep 26, 311.
10.Plourde, M & Cunnane, SC (2007) Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32, 619634.
11.Metherel, AH & Bazinet, RP (2019) Updates to the n-3 polyunsaturated fatty acid biosynthesis pathway: DHA synthesis rates, tetracosahexaenoic acid and (minimal) retroconversion. Prog Lipid Res 76, 101008.
12.von Schacky, C (2015) Omega-3 fatty acids in cardiovascular disease – an uphill battle. Prostaglandins Leukot Essent Fatty Acids 92, 4147.
13.Rice, HB, Bernasconi, A, Maki, KC et al. (2016) Conducting omega-3 clinical trials with cardiovascular outcomes: proceedings of a workshop held at ISSFAL 2014. Prostaglandins Leukot Essent Fatty Acids 107, 3042.
14.Davidson, MH, Johnson, J, Rooney, MW et al. (2012) A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study. J Clin Lipidol 6, 573584.
15.Schuchardt, JP & Hahn, A (2013) Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 89, 18.
16.Berliner, D, Mattern, S, Wellige, M et al. (2019) The omega-3 index in patients with heart failure: a prospective cohort study. Prostaglandins Leukot Essent Fatty Acids 140, 3441.
17.Baghai, TC, Varallo-Bedarida, G, Born, C et al. (2011) Major depression is associated with cardiovascular risk factors and low omega-3 index. J Clin Psychiat 72, 12421247.
18.Köhler, A, Bittner, D, Löw, A et al. (2014) Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index. Br J Nutr 104, 729736.
19.Muhlhausler, BS, Gibson, RA, Yelland, LN et al. (2014) Heterogeneity in cord blood DHA concentration: towards an explanation. Prostaglandins Leukot Essent Fatty Acids 91, 135140.
20.Grosso, G, Pajak, A, Marventano, S et al. (2014) Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS ONE 9, e96905.
21.Tavazzi, L, Maggioni, AP, Marchioli, R et al. (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372, 12231230.
22.Abdelhamid, AS, Brown, TJ, Brainard, JS et al. (2018) Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 11, CD003177.
23.Ramirez, JL, Zahner, GJ, Spaulding, KA et al. (2019) Peripheral artery disease is associated with a deficiency of erythrocyte membrane n-3 polyunsaturated fatty acids. Lipids 54, 211229.
24.Micha, R, Peñalvo, JL, Cudhea, F et al. (2017) Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA 317, 912924.
25.Chowdhury, R, Warnakula, S, Kunutsor, S et al. (2014) Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 160, 398406.
26.Chowdhury, R, Stevens, S, Gorman, D et al. (2012) Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. Br Med J 345, e6698.
27.Siscovick, DS, Barringer, TA, Fretts, AM et al. (2017) Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American heart association. Circulation 135, e867e884.
28.Rimm, EB, Appel, LJ, Chiuve, SE et al. (2018) Seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular disease: a science advisory from the American Heart Association. Circulation 138, e35e47.
29.Mozaffarian, D, Lemaitre, RN, King, IB et al. (2011) Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study. Ann Intern Med 155, 160170.
30.Harris, WS, Masson, S, Barlera, S et al. (2016) Red blood cell oleic acid levels reflect olive oil intake while omega-3 levels reflect fish intake and the use of omega-3 acid ethyl esters: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico – Heart Failure trial. Nutr Res 36, 989994.
31.Yang, B, Shi, MQ, Li, ZH et al. (2016) Fish, long-chain n-3 PUFA and incidence of elevated blood pressure: a meta-analysis of prospective cohort studies. Nutrients 8, pii: E58.
32.Filipovic, MG, Aeschbacher, S, Reiner, MF et al. (2018) Whole blood omega-3 fatty acid concentrations are inversely associated with blood pressure in young, healthy adults. J Hypertens 36, 15481554.
33.Skulas-Ray, AC, Kris-Etherton, PM, Harris, WS et al. (2011) Dose response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy people with moderate hypertriglyceridemia. Am J Clin Nutr 93, 243252.
34.Wang, Q, Liang, X, Wang, L et al. (2012) Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials. Atherosclerosis 221, 536543.
35.Miller, PE, Van Elswyk, M & Alexander, DD (2014) Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens 27, 885896.
36.Adjepong, M, Yakah, W, Harris, WS et al. (2018) Whole blood n-3 fatty acids are associated with executive function in 2–6-year-old Northern Ghanaian children. J Nutr Biochem 57, 287293.
37.Dretsch, MN, Johnston, D, Bradley, RS et al. (2014) Effects of omega-3 fatty acid supplementation on neurocognitive functioning and mood in deployed U.S. Soldiers: a pilot study. Mil Med 179, 396403.
38.Tan, ZS, Harris, WS, Beiser, AS et al. (2012) Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology 78, 658664.
39.Lukaschek, K, von Schacky, C, Kruse, J et al. (2016) Cognitive impairment is associated with low omega-3 Index in the elderly. Results from the KORA-Age study. Dementia Geriatr Cogn Dis 42, 236245.
40.Bigornia, SJ, Scott, TM, Harris, WS et al. (2018) Prospective associations of erythrocyte composition and dietary intake of n-3 and n-6 PUFA with measures of cognitive function. Nutrients 10, 1253.
41.Witte, AV, Kerti, L, Hermannstädter, HM et al. (2014) Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex 24, 30593068.
42.Külzow, N, Witte, AV, Kerti, L et al. (2016) Impact of omega-3 fatty acid supplementation on memory functions in healthy older adults. J Alzheimers Dis 51, 713725.
43.Olsen, SF, Halldorsson, TI, Thorne-Lyman, AL et al. (2018) Plasma concentrations of long chain N-3 fatty acids in early and mid-pregnancy and risk of early preterm birth. EBioMedicine 35, 325333, Correction in Olsen SF, Halldorsson TI, Thorne-Lyman AL et al. (2020) Corrigendum to 'Plasma concentrations of long chain N-3 fatty acids in early and mid-pregnancy and risk of early preterm birth. EBioMedicine. 51 102619.
44.Hoge, A, Donneau, AF, Dardenne, N et al. (2020) Impact of erythrocyte long-chain omega-3 polyunsaturated fatty acid levels in early pregnancy on birth outcomes: findings from a Belgian cohort study. J Perinatol 40, 488496.
45.Hoge, A, Tabar, V, Donneau, AF et al. (2019) Imbalance between omega-6 and omega-3 polyunsaturated fatty acids in early pregnancy is predictive of postpartum depression in a Belgian cohort. Nutrients 11, pii: E876.
46.Middleton, P, Gomersall, JC, Gould, JF et al. (2018) Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev 11, CD003402.
47.Gellert, S, Schuchardt, JP & Hahn, A (2016) Higher omega-3 index and DHA status in pregnant women compared to lactating women – results from a German nation-wide cross-sectional study. Prostaglandins Leukot Essent Fatty Acids 109, 2228.
48.von Schacky, C, Haslbauer, R, Kemper, M et al. (2014) Low omega-3 index in 106 German elite winter endurance athletes – a pilot study. Int J Sport Nutr Exerc Metab 24, 559564.
49.Anzalone, A, Carbuhn, A, Jones, L et al. (2019) The omega-3 index in national collegiate athletic association division I collegiate football athletes. J Athl Train 54, 711.
50.Davinelli, S, Corbi, G, Righetti, S et al. (2019) Relationship between distance run per week, omega-3 index, and arachidonic acid (AA)/eicosapentaenoic acid (EPA) ratio: an observational retrospective study in non-elite runners. Front Physiol 10, 487.
51.Kim, J & Lee, J (2014) A review of nutritional intervention on delayed onset muscle soreness. Part I. J Exerc Rehabil 10, 349356.
52.Ochi, E & Tsuchiya, Y (2018) Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in muscle damage and function. Nutrients 10, pii: E552.
53.Burri, L, Wyse, C, Gray, SR et al. (2018) Effects of dietary supplementation with krill meal on serum pro-inflammatory markers after the Iditarod sled dog race. Res Vet Sci 121, 1822.
54.Hudek, R, von Schacky, C, Passow, A et al. (2019) Degenerative rotator cuff tears are associated with a low omega-3 index. Prostaglandins Leukot Essent Fatty Acids 148, 3540.
55.Oliver, JM, Jones, MT, Kirk, KM et al. (2016) Effect of docosahexaenoic acid on a biomarker of head trauma in American football. Med Sci Sports Exerc 48, 974982.
56.Guzmán, JF, Esteve, H, Pablos, C et al. (2011) DHA- rich fish oil improves complex reaction time in female elite soccer players. J Sports Sci Med 10, 301335.
57.Kleber, ME, Delgado, GE, Dawczynski, C et al. (2016) Saturated fatty acids and mortality in patients referred for coronary angiography – the Ludwigshafen risk and cardiovascular health study. J Clin Lipidol 12, 455463.
58.Huang, L, Lin, JS, Aris, IM et al. (2019) Circulating saturated fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Nutrients 11, 5.
59.Zhu, Y, Tsai, MY, Sun, Q et al. (2018) A prospective and longitudinal study of plasma phospholipid saturated fatty acid profile in relation to cardiometabolic biomarkers and the risk of gestational diabetes. Am J Clin Nutr 107, 10171026.
60.Carta, G, Murru, E, Banni, S et al. (2017) Palmitic acid: physiological role, metabolism and nutritional implications. Front Physiol 8, 902.
61.Bonafini, S, Tagetti, A, Gaudino, R et al. (2019) Individual fatty acids in erythrocyte membranes are associated with several features of the metabolic syndrome in obese children. Eur J Nutr 58, 731742.
62.Jang, H & Park, K (2020) Omega-3 and omega-6 polyunsaturated fatty acids and metabolic syndrome: a systematic review and meta-analysis. Clin Nutr 39, 767773.
63.Castro-Marreroa, J, Zaragozáa, MC, Domingo, JC et al. (2018) Low omega-3 index and polyunsaturated fatty acid status in patients with chronic fatigue syndrome/myalgic encephalomyelitis: myth or reality? Prostaglandins Leukot Essent Fatty Acids 139, 2024.
64.van der Wurff, I, von Schacky, C, Bergeland, T et al. (2019) Effect of 1 year krill oil supplementation on cognitive achievement of Dutch adolescents: a double-blind randomized controlled trial. Nutrients 11, pii: E1230.
65.Schättin, A, Baier, C, Mai, D et al. (2019) Effects of exergame training combined with omega-3 fatty acids on the elderly brain: a randomized double-blind placebo-controlled trial. BMC Geriatr 19, 81.
66.von Schacky, C (2019) Verwirrung um die Wirkung von omega-3 Fettsäuren. Betrachtung von Studiendaten unter Berücksichtigung des omega-3 index. [Confusion about the effects of omega-3 fatty acids: contemplation of study data taking the omega-3 Index into consideration]. Internist (Berl) 60, 13191327.

Keywords

Omega-3 index in 2018/19

  • Clemens von Schacky (a1)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.